M. Kroese

Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship

H. Putter, S. Oerlemans, I. Jürgenliemk-Schulz, 2022 .

The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors

P. Roholl, D. Rutgers, J. van Unnik, 1990, Cancer.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

H. Putter, T. Bosse, B. van Triest, 2018, British Journal of Cancer.

The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor.

S. Siesling, E. M. van der Steen-Banasik, J. van der Palen, 2010, Gynecologic oncology.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

T. Bosse, B. van Triest, W. van Putten, 2018, British Journal of Cancer.